SLCO1B1 c.970+668G>T

Variant ID: 12-21350790-G-T

NM_006446.4(SLCO1B1):c.970+668G>T

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Genomic markers associated with successful treatment of hypertension with lisinopril: A pilot study.

International Journal Of Clinical Pharmacology And Therapeutics
Flaten, Hania K HK; Sonn, Brandon J BJ; Saben, Jessica L JL; Shelton, Shelby K SK; Schwartz, John J; Ryall, Karen K; Monte, Andrew A AA
Publication Date: 2021-07

Variant appearance in text: rs4149063
PubMed Link: 33769277
Variant Present in the following documents:
  • Main text
  • intjclinpharmacol-59-506.pdf
View BVdb publication page



Whole genome sequencing identifies high-impact variants in well-known pharmacogenomic genes.

The Pharmacogenomics Journal
Choi, Jihoon J; Tantisira, Kelan G KG; Duan, Qing Ling QL
Publication Date: 2019-04

Variant appearance in text: rs4149063
PubMed Link: 30214008
Variant Present in the following documents:
  • NIHMS1503453-supplement-3.xlsx, sheet 1
View BVdb publication page



SLCO1B1 variants and urine arsenic metabolites in the Strong Heart Family Study.

Toxicological Sciences : An Official Journal Of The Society Of Toxicology
Gribble, Matthew O MO; Voruganti, Venkata Saroja VS; Cropp, Cheryl D CD; Francesconi, Kevin A KA; Goessler, Walter W; Umans, Jason G JG; Silbergeld, Ellen K EK; Laston, Sandra L SL; Haack, Karin K; Kao, Wen Hong Linda WH; Fallin, Margaret Daniele MD; Maccluer, Jean W JW; Cole, Shelley A SA; Navas-Acien, Ana A
Publication Date: 2013-11

Variant appearance in text: rs4149063
PubMed Link: 23970802
Variant Present in the following documents:
  • Main text
View BVdb publication page